Doctors and scientists who spoke to HuffPost are worried for a multitude of reasons and want you to know that this will ...

Scientists say HHS’s decision to stop investing in mRNA vaccine research is another sign of the growing politicization of ...

Prof. Benjamin Aribisala, the Director of Lagos State University Centre of Excellence for Sargassum Research, writes from ...

Vietnamese electric vehicle maker VinFast Auto Ltd. announced plans to spin off part of its research and development unit ...

On Aug. 5, Robert F. Kennedy Jr. posted video to X announcing HHS was canceling mRNA vaccine research, confusing the Trump ...

The deal would be the latest cash injection by billionaire Pham Nhat Vuong to make loss-making VinFast a viable player in the ...

VinFast's founder Pham Nhat Vuong has agreed to buy the EV maker's research and development arm for $1.52 billion, his latest ...

Net loss (GAAP) narrowed to $6.1 million in Q2 2025, a 22.8% improvement from the prior-year period, driven by reduced research and development spending. No product revenue reported; The company’s ...

Cash, cash equivalents, and short-term investments stood at $227.0 million as of Q2 2025, expected to fund operations into the fourth quarter of 2026 based on balances as of June 30, 2025. These 10 ...

Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage trial, ...

Can Boston stay on top in biotech? Find out on Sept 17, 6-9 p.m. EDT to explore talent shifts, funding, and Boston’s future.

The Blast Overpressure Tool, developed to minimize exposure to shock waves generated by heavy weapon fire, now incorporates ...